Related Experiment Video
Updated: Feb 10, 2026

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials
Published on: April 10, 2016
Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial
J C Cho1, L M Childs-Kean2, M T Zmarlicka3
1College of Pharmacy, The University of Texas at Tyler, Tyler, Texas, USA. jcho@uttyler.edu.
Abstract:
Omadacycline is a novel aminomethylcycline antimicrobial agent that is available in both oral and intravenous formulations. The distinguishing structural characteristics of omadacycline from other tetracyclines allow for its continued antimicrobial activity in the presence of traditional tetracycline resistance mechanisms (efflux pumps and ribosomal protection proteins). Omadacycline has been found to have potent activity against antibiotic-resistant pathogens including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, extended spectrum beta-lactamase-producing Escherichia coli and multidrug-resistant Streptococcus pneumoniae. Currently available data indicate that omadacycline is generally well tolerated with the most common adverse effects being gastrointestinal symptoms. Omadacycline seems to be a promising new agent for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Studies for the treatment of cystitis in adult females are currently underway, and future results of these studies will further help delineate the antibacterial role of omadacycline.
Insights
Omadacycline, a novel aminomethylcycline antibiotic, shows potent activity against resistant bacteria. It is a promising treatment for infections like pneumonia and skin infections, with manageable side effects.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Tetracycline resistance is a growing global health concern.
- Novel antibiotics are needed to combat resistant bacterial strains.
- Omadacycline is a new aminomethylcycline with unique structural properties.
Purpose of the Study:
- To evaluate the antimicrobial activity of omadacycline.
- To assess the efficacy of omadacycline in treating bacterial infections.
- To characterize the safety and tolerability profile of omadacycline.
Main Methods:
- In vitro susceptibility testing against resistant pathogens.
- Clinical studies for community-acquired bacterial pneumonia and skin infections.
- Monitoring of adverse events in clinical trials.
Main Results:
- Omadacycline demonstrated potent activity against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and other resistant bacteria.
- The drug is effective for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
- Gastrointestinal symptoms were the most common adverse effects, indicating good tolerability.
Conclusions:
- Omadacycline is a promising novel antibiotic agent.
- Its unique structure overcomes common tetracycline resistance mechanisms.
- Further studies are ongoing for other indications like cystitis.
Related Concept Videos
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Nuclear Export of mRNA

